Supporting this possibility is the finding that pharmacologic inhibition of PERK protects against DPR aggregation and neurotoxicity in both fly and mouse models of C9orf72-ALS [130]. This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.